Lan Gao

机构：Nanjing University of Chinese Medicine, China Pharmaceutical University, Jiangning District of Nanjing Chinese Medicine Hospital, PTC Therapeutics (United States) · ORCID：0000-0002-2528-7656

发表论文 80 篇 · 总被引 1605 次 · h-index 21

代表论文

• Relative Oral Bioavailability and Food Effects of Two Sepiapterin Formulations in Healthy Participants (2023 · Clinical Pharmacology in Drug Development · 被引 14)
• Pharmacokinetics and pharmacodynamics of PTC518, an oral huntingtin lowering splicing modifier: A first‐in‐human study (2024 · British Journal of Clinical Pharmacology · 被引 13)
• First‐in‐Human Studies of Pharmacokinetics and Safety of Utreloxastat (PTC857), a Novel 15‐Lipooxygenase Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis (2022 · Clinical Pharmacology in Drug Development · 被引 13)
• Validation and application of volumetric absorptive microsampling (VAMS) dried blood method for phenylalanine measurement in patients with phenylketonuria (2023 · Clinical Biochemistry · 被引 12)
• A Phase 1 Study to Assess the Pharmacokinetics, Food Effect, Safety, and Tolerability of Sepiapterin in Healthy Japanese and Non-Japanese Participants (2024 · Pharmaceuticals · 被引 9)
• Propofol enhances the lethality of cisplatin on liver cancer cells by up-regulating miR-195-5p (2021 · Tissue and Cell · 被引 7)